Table I.

Oligonucleotide primers used in this study^a

Organism/Gene	Method	Forward Sequence (5′→3′)	Reverse Sequence (5′→3′)
R, GAPDH	PCR	TTCAATGGCACAGTCAAGGC	TCACCCCATTTGATGTTAGCG
R, HIF-1α	PCR	CGAGCTGCCTCTTCGACAAG	CCCAGCCGCTGGAGCTA
R, RANTES	PCR	TGCCCACGTGAAGGAGTATTT	TTCTTCTCTGGGTTGGCACAC
H, GAPDH	PCR	AACCTGCCAAGTACGATGACATC	GTAGCCCAGGATGCCCTTGA
H, HIF-1α	PCR	CTCAAAGTCGGACAGCCTCA	CCCTGCAGTAGGTTTCTGCT
H, RANTES	PCR	TGCCCACGTGAAGGAGTATTT	TTCTTCTCTGGGTTGGCACAC
H, RANTES-HRE-M3	SDM	CTCAAAGACATTAAGATCTTTTCCCAAAGGTCGCTTAGCAAG	CTTGCTAAGCGACCTTTGGGAAAAGATCTTAATGTCTTTGAG
H, RANTES-HRE-M2	SDM	CCTGCAGAGGATCAAGACAGCGTCTGGACCTCGC	GCGAGGTCCAGACGCTGTCTTGATCCTCTGCAGG
H, RANTES-HRE-M1	SDM	GCACGTGGACCTCGATCAGCCTCTCCCACA	CATGGTACCTGTGGGAGAGGCTGATCGAGGTCC
H, RANTES-AP-1-M	SDM	GTGCTTGGTCAAAGAGGAAACTGATACAGCCACTCTAGATGAGAGAGCAGTG	CACTGCTCTCTCATCTAGAGTGGCTGTATCAGTTTCCTCTTTGACCAAGCAC
H, RANTES wt HRE1 consensus oligonucleotides	EMSA	GTGGACCTCGCACAGCCTCTCC	GGAGAGGCTGTGCGAGGTCCAC
H, RANTES mutant HRE1 consensus oligonucleotides	EMSA	GTGGACCTCGATCAGCCTCTCC	GGAGAGGCTGATCGAGGTCCAC
H, RANTES wt AP1 consensus oligonucleotides	EMSA	GAAACTGATGAGCTCACTCTAG	CTAGAGTGAGCTCATCAGTTTC
H, RANTES mutant AP1 consensus oligonucleotides	EMSA	GAAACTGATACAGCCACTCTAG	CTAGAGTGGCTGTATCAGTTTC
H, RANTES	ChIP	AAAGAGGAAACTGATGAGCT	GTACCTGTGGGAGAGGCT

^aH, Human; R, rat; SDM, site-directed mutagenesis. Site-specific mutations are depicted in bold.